|
E24CHA001 |
EnoGene |
Human-,-Human-IgG1. |
EUR 276.5 |
Description: Human, Human IgG1. |
Human IgG antibody Laboratories manufactures the have sars antibodies been developed reagents distributed by Genprice. The Have Sars Antibodies Been Developed reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact SARS Antibody. Other Have products are available in stock. Specificity: Have Category: Sars Group: Antibodies Been
Human Platelet Antibodies IgG (PA-IgG) ELISA Kit |
MyBiosource |
10x96-Strip-Wells |
EUR 6725 |
Human Platelet Antibodies IgG (PA-IgG) ELISA Kit |
MyBiosource |
48-Strip-Wells |
EUR 550 |
Human Platelet Antibodies IgG (PA-IgG) ELISA Kit |
MyBiosource |
5x96-Strip-Wells |
EUR 3420 |
Human Platelet Antibodies IgG (PA-IgG) ELISA Kit |
MyBiosource |
96-Strip-Wells |
EUR 765 |
Human Platelet IgG antibodies (PA-IgG) ELISA Kit |
MyBiosource |
10x96-Strip-Wells |
EUR 6255 |
Human Platelet IgG antibodies (PA-IgG) ELISA Kit |
MyBiosource |
48-Strip-Wells |
EUR 445 |
Human Platelet IgG antibodies (PA-IgG) ELISA Kit |
MyBiosource |
5x96-Strip-Wells |
EUR 3290 |
Antibodies Been information
SARS-CoV-2 Spike RBD (B.1.617.2) Specific ELISA Kit (For Vaccine Development) |
RAS-A092 |
ACROBIOSYSTEMS |
96tests |
EUR 845.3 |
- The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective assay kit detecting the levels of SARS-CoV-2 Spike protein is urgently needed to accelerate the develo
- Show more
|
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective assay kit detecting the levels of SARS-CoV-2 Spike protein is urgently needed to accelerate the development of COVID-19 vaccines. |
SARS-CoV-2 Spike Trimer (B.1.617.2) Specific ELISA Kit (For Vaccine Development) |
RAS-A055 |
ACROBIOSYSTEMS |
96tests |
EUR 845.3 |
- The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective assay kit detecting the levels of SARS-CoV-2 Spike protein is urgently needed to accelerate the develo
- Show more
|
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective assay kit detecting the levels of SARS-CoV-2 Spike protein is urgently needed to accelerate the development of COVID-19 vaccines. |
SARS-CoV-2 Spike Trimer (B.1.1.529) Specific ELISA Kit (For Vaccine Development) |
RAS-A081 |
ACROBIOSYSTEMS |
96tests |
EUR 845.3 |
- The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective assay kit detecting the levels of SARS-CoV-2 Spike protein is urgently needed to accelerate the develo
- Show more
|
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective assay kit detecting the levels of SARS-CoV-2 Spike protein is urgently needed to accelerate the development of COVID-19 vaccines. |
SARS-CoV-2 Spike Trimer (BA.4) Specific ELISA Kit (For Vaccine Development) |
RAS-A124 |
ACROBIOSYSTEMS |
96tests |
EUR 845.3 |
- The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective assay kit detecting the levels of SARS-CoV-2 Spike protein is urgently needed to accelerate the develo
- Show more
|
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective assay kit detecting the levels of SARS-CoV-2 Spike protein is urgently needed to accelerate the development of COVID-19 vaccines. |
SARS-CoV-2 Spike Trimer (BA.5) Specific ELISA Kit (For Vaccine Development) |
RAS-A125 |
ACROBIOSYSTEMS |
96tests |
EUR 845.3 |
- The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective assay kit detecting the levels of SARS-CoV-2 Spike protein is urgently needed to accelerate the develo
- Show more
|
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective assay kit detecting the levels of SARS-CoV-2 Spike protein is urgently needed to accelerate the development of COVID-19 vaccines. |
SARS-CoV-2 Spike RBD (BA.4 & BA.5) Specific ELISA Kit (For Vaccine Development) |
RAS-A126 |
ACROBIOSYSTEMS |
96tests |
EUR 845.3 |
- The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective assay kit detecting the levels of SARS-CoV-2 Spike protein is urgently needed to accelerate the develo
- Show more
|
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective assay kit detecting the levels of SARS-CoV-2 Spike protein is urgently needed to accelerate the development of COVID-19 vaccines. |
SARS-CoV-2 Spike RBD (Wild Type) Specific ELISA Kit (For Vaccine Development) |
RAS-A116 |
ACROBIOSYSTEMS |
96tests |
EUR 845.3 |
- The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective assay kit detecting the levels of SARS-CoV-2 Spike protein is urgently needed to accelerate the develo
- Show more
|
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective assay kit detecting the levels of SARS-CoV-2 Spike protein is urgently needed to accelerate the development of COVID-19 vaccines. |
SARS-CoV-2 Neutralization Assay Development Kit (Delta Variant RBD-ACE2) |
NTRL-DT-RBD-10 |
The Native Antigen Company |
10 x 96-well plates |
EUR 2390.76 |
|
Description: SARS-CoV-2 Neutralization Assay Development Kit (Delta Variant RBD-ACE2) |
SARS-CoV-2 Neutralization Assay Development Kit (Kerala Variant RBD-ACE2) |
NTRL-IN-RBD-10 |
The Native Antigen Company |
10 x 96-well plates |
EUR 2390.76 |
|
Description: SARS-CoV-2 Neutralization Assay Development Kit (Indian Variant RBD-ACE2) |
SARS-CoV-2 Neutralization Assay Development Kit (Lambda Variant RBD-ACE2) |
NTRL-LD-RBD-10 |
The Native Antigen Company |
10 x 96-well plates |
EUR 2390.76 |
|
Description: SARS-CoV-2 Neutralization Assay Development Kit (Lambda Variant RBD-ACE2) |
SARS-CoV-2 Spike Trimer (Wild Type) Specific ELISA Kit (For Vaccine Development) |
RAS-A115 |
ACROBIOSYSTEMS |
96tests |
EUR 845.3 |
- The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective assay kit detecting the levels of SARS-CoV-2 Spike protein is urgently needed to accelerate the develo
- Show more
|
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective assay kit detecting the levels of SARS-CoV-2 Spike protein is urgently needed to accelerate the development of COVID-19 vaccines. |
SARS-CoV-2 Neutralization Assay Development Kit (Brazilian Variant RBD-ACE2) |
NTRL-BZ-RBD-10 |
The Native Antigen Company |
10 x 96-well plates. |
EUR 2390.76 |
|
Description: SARS-CoV-2 Neutralization Assay Development Kit (Brazilian Variant RBD-ACE2) |
SARS-CoV-2 Neutralization Assay Development Kit (Omicron Variant SPIKE-ACE2) |
NTRL-OMI-SPIKE-10 |
The Native Antigen Company |
10 x 96-well plates |
EUR 2390.76 |
|
Description: SARS-CoV-2 Neutralization Assay Development Kit (Omicron Variant Spike-ACE2) |
SARS-CoV-2 Neutralization Assay Development Kit (South African Variant RBD-ACE2) |
NTRL-SA-RBD-10 |
The Native Antigen Company |
10 x 96-well plates |
EUR 2390.76 |
|
Description: SARS-CoV-2 Neutralization Assay Development Kit (South African Variant RBD-ACE2) |
SARS-CoV-2 Neutralization Assay Development Kit (South African Variant RBD-ACE2) |
NTRL-UK-RBD-10 |
The Native Antigen Company |
10 x 96-well plates |
EUR 2390.76 |
|
Description: SARS-CoV-2 Neutralization Assay Development Kit (United Kingdom Variant RBD-ACE2) |
HDAC developer (2X) |
50030 |
BPS Bioscience |
6 ml |
EUR 230 |
Description: HDAC assay developer is an essential reagent for signal generation in HDAC assays performed with any of BPS Bioscience's HDAC fluorimetric substrates or assay kits. An appropriate fluorimetric substrate, comprising an acetylated lysine side chain, is first incubated with a sample containing HDAC activity (nuclear or cellular extract, purified enzyme, bead-bound immunocomplex, etc.). Deacetylation of the substrate sensitizes it so that, in a second step, treatment with the HDAC assay developer produces a fluorophore. Trichostatin A is included as an 'inhibitor stop' for class I and II HDACs. |